Primary Care POC Diagnostics Market Size Worth $8.6 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, March 12, 2018 /PRNewswire/ --

The global primary care POC diagnostics market size is expected to reach USD 8.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.5% CAGR during the forecast period. Flexible and forward-thinking core molecular labs have been embracing and supporting the use of POC tests to move screening of many common targets to hospital receiving rooms and physicians' offices.

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

As per a study conducted by the American Journal of Clinical Pathology in 2014, it was found that POC testing improved clinical operations for manufacturers by reducing follow-up calls and letters of patients by 85.0% and 89.0%, respectively, and reducing their follow-up visits by 61.0%. It was also observed that the number of tests ordered decreased by 21.0%.

Furthermore, rise in the number of tests receiving a waived status under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) is anticipated to aid market growth. Researchers and manufacturers are increasingly recommending these tests owing to cost reduction of about USD 12-15 per patient and reduction in follow up tests by about 50.0%. However, there is a massive overlap between different methods and their areas of usage. For instance, panels to measure glucose and quick international normalized ratio tests were originally meant for self-testing but are now used in hospitals and primary settings instead.

Browse full research report with TOC on "Primary Care POC Diagnostics Market Size & Share Analysis Report By Product (Glucose Testing, Lipid Testing, Drug Abuse Testing), By End Use (Pharmacy & Retail Clinics, Physician Office), And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/primary-care-poc-diagnostics-market

Further key findings from the report suggest: 

• Adoption of advanced imaging technologies is augmenting the growth of MRI market
• The closed system segment accounted for the largest share in 2015. Whereas open system is anticipated to be the fastest growing segment during the forecast period.
• MRI for neural and brain disorders dominated the market since no alternate scanning tool is available  
• In 2015, North America dominated the global space with the largest revenue share owing to continuous research and high adoption of advanced techniques  
• Asia Pacific is anticipated to show the fastest growth rate during the forecast period from 2016 to 2025
• Rapidly growing medical tourism industry coupled with growing disposable income of India, and China are some of the factors that are expected to drive the market growth
• Major players competing in the industry include but are not limited to Siemens AG; Koninklijke Philips N.V.; GE Healthcare; Hitachi Medical Systems

Browse related reports by Grand View Research: 

• Malaria Diagnostics Market - The global malaria diagnostics market size was valued at USD 604.3 million in 2016 and is anticipated to witness a CAGR of 4.5% during the forecast period.

• Computer Aided Detection (CAD) Market - The global Computer Aided Detection (CAD) market size was valued at USD 402.9 million in 2014. Increasing cancer prevalence and rising awareness in the population for regular health check-ups are the most significant drivers of the global CAD industry.

• In-Vitro Colorectal Cancer Screening Tests Market  - The global in-vitro colorectal cancer screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period.

• In-vitro Toxicology Testing Market  - The global in-vitro toxicology testing market size was valued at USD 20.2 billion in 2014. Growing preference for in-vitro toxicology tests over the conventional in-vivo tests is anticipated to drive demand in the sector. 

Grand View Research has segmented the global primary care POC diagnostics market on the basis of products, end use, and region: 

• Primary Care POC Diagnostics Product Outlook (Revenue, USD Million, 2014 - 2025) 

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

• Primary Care POC Diagnostics End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Pharmacy & Retail Clinics
  • Pharmacy & Retail Clinics, By Product
    • Glucose Testing
    • Hb1Ac Testing
    • Coagulation
    • Fertility
    • Infectious Diseases
    • Cardiac Markers
    • Thyroid Stimulating Hormone
    • Hematology
    • Primary Care Systems
    • Decentralized Clinical Chemistry
    • Feces
    • Lipid Testing
    • Cancer Marker
    • Blood Gas/Electrolytes
    • Ambulatory Chemistry
    • Drug Abuse Testing
    • Urinalysis
• Physician Office
  • Physician Office, By Product
    • Glucose Testing
    • Hb1Ac Testing
    • Coagulation
    • Fertility
    • Infectious Diseases
    • Cardiac Markers
    • Thyroid Stimulating Hormone
    • Hematology
    • Primary Care Systems
    • Decentralized Clinical Chemistry
    • Feces
    • Lipid Testing
    • Cancer Marker
    • Blood Gas/Electrolytes
    • Ambulatory Chemistry
    • Drug Abuse Testing
    • Urinalysis
• Urgent Care Clinics
  • Urgent Care Clinics, By Product
    • Glucose Testing
    • Hb1Ac Testing
    • Coagulation
    • Fertility
    • Infectious Diseases
    • Cardiac Markers
    • Thyroid Stimulating Hormone
    • Hematology
    • Primary Care Systems
    • Decentralized Clinical Chemistry
    • Feces
    • Lipid Testing
    • Cancer Marker
    • Blood Gas/Electrolytes
    • Ambulatory Chemistry
    • Drug Abuse Testing
    • Urinalysis
• Non-practice Clinics
  • Non-practice Clinics, By Product
    • Glucose Testing
    • Hb1Ac Testing
    • Coagulation
    • Fertility
    • Infectious Diseases
    • Cardiac Markers
    • Thyroid Stimulating Hormone
    • Hematology
    • Primary Care Systems
    • Decentralized Clinical Chemistry
    • Feces
    • Lipid Testing
    • Cancer Marker
    • Blood Gas/Electrolytes
    • Ambulatory Chemistry
    • Drug Abuse Testing
    • Urinalysis

• Primary Care POC Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025) 

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Nigeria
  • Qatar
  • Kenya
  • Zimbabwe

Read Our Blog: https://www.grandviewresearch.com/blogs/healthcare

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com